HS-20105
/ Jiangsu Hansoh Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 01, 2024
Study of HS-20105 for Injection in Patients With Advanced Solid Tumors.
(clinicaltrials.gov)
- P1/2 | N=402 | Not yet recruiting | Sponsor: Hansoh BioMedical R&D Company
Metastases • Trial primary completion date • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1